| 骨髓增生异常综合征预后的研究进展 |
| |
| 引用本文： | 王婧瑶,徐绍涵,徐俊卿,初晓霞.骨髓增生异常综合征预后的研究进展[J].安徽医药,2021,25(7):1277-1281. |
| |
| 作者姓名： | 王婧瑶 徐绍涵 徐俊卿 初晓霞 |
| |
| 作者单位： | 青岛大学医学部,山东 青岛266000;承德医学院,河北 承德067000;青岛大学医学院附属烟台毓璜顶医院血液内科,山东 烟台264000 |
| |
| 摘 要： | 骨髓增生异常综合征的预后具有明显的异质性,近年来随着国际预后积分系统和修订版国际预后积分系统等的提出,使得对于该病的预后判断更为准确,据此制定病人的治疗策略也更趋合理.随着细胞和分子遗传学研究的不断深入,一些新的重要的预后因素也得以不断地确认.本研究就该领域的研究现状做一简要概述.
|
| 关 键 词： | 骨髓增生异常综合征 预后积分系统 分子遗传学 铁蛋白 |
Research progress on prognosis of myelodysplastic syndromes |
| |
| WANG Jingyao,XU Shaohan,XU Junqing,CHU Xiaoxia.Research progress on prognosis of myelodysplastic syndromes[J].Anhui Medical and Pharmaceutical Journal,2021,25(7):1277-1281. |
| |
| Authors: | WANG Jingyao XU Shaohan XU Junqing CHU Xiaoxia |
| |
| Institution: | Department of Medicine, Qingdao university, Qingdao, Shandong 266000, China;Chengde Medical College, Chengde, Hebei 067000, China;Department of Hematology, Yuhuangding Yantai Hospital Affiliated to Qingdao University Medical College, Yantai, Shandong 264000,China |
| |
| Abstract: | The prognosis of myelodysplastic syndromes is obviously heterogeneous. In recent years, with the introduction of International Prognostic Scoring System and Revised vertion of the International Prognostic Scoring System, the prognosis of the disease ismore accurate. With the development of the cell and molecular genetics, some important prognostic factors have been identified. Thispaper gives a brief overview of the current research in this field. |
| |
| Keywords: | Myelodysplastic syndromes Prognostic score system Molecular genetics Ferroprotein |
| 本文献已被 万方数据 等数据库收录！ |
| 点击此处可从《安徽医药》浏览原始摘要信息 |
| 点击此处可从《安徽医药》下载免费的PDF全文 |
|
